Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...
A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...
The severity of left ventricular diastolic dysfunction affects risk for incident stroke and transient ischemic attack, as well as major bleeding.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback